medigraphic.com
SPANISH

Revista Cubana de Medicina Tropical

ISSN 1561-3054 (Electronic)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2022, Number 1

<< Back Next >>

Rev Cubana Med Trop 2022; 74 (1)

Imported non-falciparum malaria: aspects of interest for patient therapeutic management

Menéndez CRL, Pomier SO
Full text How to cite this article

Language: Spanish
References: 25
Page:
PDF size: 286.20 Kb.


Key words:

non falciparum malaria, delayed response, chloroquine.

ABSTRACT

Introduction: Malaria is a potentially fatal acute febrile illness caused by parasites transmitted by the Anopheles mosquito. Non-falciparum malaria (NFM), caused by other Plasmodium species, is less documented in the international literature, despite its prevalence.
Objectives: To describe clinical and epidemiological aspects of interest for the treatment of patients hospitalized with a diagnosis of imported NFM, and to determine the relationship between response to treatment and other variables.
Methods: It was conducted an analytical cross-sectional study of 89 adult patients with imported NFM, admitted to the Department of Medicine of the Institute of Tropical Medicine Pedro Kourí, between January 1997 to December 2017. The prophylaxis and treatment guideline was determined according to the published guidelines and drugs available in Cuba, and the definition of severe malaria by WHO in 2003. There was delayed response to treatment when the patient took more than 7 days to become negative for thick blood smear.
Results: Patients were predominantly male, with a mean age of 37.2 years. Plasmodium vivax was isolated in 85.4% of the patients and 55.1% were from the Americas region. The response to treatment was excellent with the chloroquine-based combination regimens used. The relationship between the delayed response to treatment and the severity of the clinical picture and the non-immune status of the patients was significant.
Conclusions: NFM is an important cause of imported malaria in patients from endemic areas, mainly from the Americas. It is characterized by low parasitemia, clinical manifestations of fever, chills, headache and evolution towards uncomplicated symptoms. Chloroquine was the drug of choice, although the delayed response to treatment does not justify its suspension or variation.


REFERENCES

  1. OMS. Paludismo. Ginebra: OMS; Nota descriptiva 30 noviembre 2020. [Acceso 14/07/2021]. Disponible en: Disponible en: http://www.who.int/es/newsroom/factsheets/detail/malaria

  2. Kain KC, Keystone JS. Malaria in travelers. Epidemiology, disease, and prevention. Infect Dis Clin North Am. 1998;12:267-84.

  3. Camargo M, Soto-de León SC, del Río-Ospina L, Páez AC, González Z, González E, et al. Micro-epidemiology of mixed species malaria infections in a rural population living in the Colombian Amazon region. Scientific Reports. 2018;8:5543. DOI: https://doi.org/10.1038/s41598-018-23801

  4. OMS. Epidemias de paludismo y emergencias. Ginebra: OMS; Actualización 22 enero 2018. [Acceso 22/06/2018]. Disponible en: Disponible en: http://www.who.int/malaria/areas/epidemics_emergencies/es

  5. OMS. Severe falciparum malaria. World Health Organization, Communicable Diseases Cluster. Trans R Soc Trop Med Hyg. 2014 Apr [Acceso 30/06/2021];94(Suppl 1):S1-90. Disponible en: Disponible en: https://pubmed.ncbi.nlm.nih.gov/11103309/ PMID: 11103309

  6. Gautret P, Schlagenhauf P, Gaudart J, Castelli F, Brouqui P, von Sonnenburg F, et al. Multicenter Euro Trav Net/Geo Sentinel study of travel-related infectious diseases in Europe. Emerg Infect Dis. 2009 [Acceso 30/06/2021];15:1783-90. Disponible en: Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2857260/

  7. Fernández Martínez B, Gómez Barroso D, Díaz García O, Cano Portero R. Situación del paludismo en España. Evolución del tipo de notificación a la Red Nacional de Vigilancia Epidemiológica y resumen de los resultados de la vigilancia de 2014 a 2017. Revista-ISCIII. 2018 [Acceso 30/06/2021];26(7). Disponible en: Disponible en: http://revista.isciii.es/index.php/bes/article/view/1073/132

  8. Cox-Singh J, Singh B. Knowlesi malaria: newly emergent and of public health importance? Trends Parasitol. 2008 [Acceso 30/06/2021];24:406-10. Disponible en: Disponible en: https://pubmed.ncbi.nlm.nih.gov/18678527/

  9. Kaisar MM, Supali T, Wiria AE, Hamid F, Wammes LJ, Sartono E, et al. Epidemiology of Plasmodium infections in Flores Island, Indonesia using real-time PCR. Malar J. 2013 [Acceso 30/06/2021];12:169. Disponible en: Disponible en: https://malariajournal.biomedcentral.com/articles/10.1186/1475-2875-12-169

  10. (S. a). El primer diagnóstico de certeza de paludismo hecho en Cuba. Cuad Hist Salud Pública. 2004 Ener-Jun [Acceso 20/06/2020];95. Disponible en: Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0045-91782004000100018&lng=es&nrm=iso

  11. OMS-OPS. Informe para la certificación y registro de la erradicación de la malaria en Cuba. La Habana: OPS/OMS. Documento oficial. Washington, DC; 1972. p. 114-16.

  12. Suárez Miranda CJ, Pérez A, Pérez Carreras A, Fuentes González O. Vigilancia de malaria en viajeros internacionales residentes en Ciudad de La Habana, 2000-2001. Rev Cub Salud Pública. 2004 [Acceso 20/06/2016];30(3). Disponible en: Disponible en: http://bvs.sld.cu/revistas/spu/vol30_3_04/spu 04304.htm

  13. WHO. From malaria control to malaria elimination: a manual for elimination scenario planning. Geneva: WHO; 2014. [Acceso 24/04/2019]. Disponible en: Disponible en: http://www.who.int/malaria/publications/atoz/978 9241507028/en/

  14. Miranda Reyes S, Muñiz Sabin Z, Pérez Pérez I, Palú Orozco A, García Vidal A. Acciones para el control de un brote de transmisión local de paludismo introducido en Santiago de Cuba. MEDISAN. 2009 [Acceso 20/06/2016];13(3). Disponible en: Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S102930192009000300007&nrm=iso

  15. Jiménez Prieto Y, Mendoza Acosta M, Fernández Cárdenas N, Marrero García M. Malaria importada en Villa Clara en los últimos diez años. 8th Cuban Congress on Microbiology and Parasitology, 5th National Congress on Tropical Medicine and 5th International Symposium on HIV/aids infection in Cuba. 2014. [Acceso 20/06/2016]. Disponible en: Disponible en: http://www.microbio_parasito_sida_med_tropical.sld.cu/index.php/microbiologia/2014/paper/view/670/0

  16. Chao X, Qing-Kuan W, Jin L, Ting X, Kun Y, Chang-Lei Z, et al. Characteristics of Imported Malaria and Species of Plasmodium Involved in Shandong Province, China (2012-2014). Korean J Parasitol. 2016 August;54(4):407-14. DOI: http://dx.doi.org/10.3347/kjp.2016.54.4.407

  17. Ruas R, Pinto A, Nuak J, Sarmento A, Abreu C. Non-falciparum malaria imported mainly from Africa: a review from a Portuguese hospital. Malar J. 2017;16:298. DOI: http://dx.doi.org/10.1186/s12936-017-1952-3

  18. Muñoz J, Rojo-Marcos G, Ramírez-Olivencia G, Salas-Coronas J, Treviño B, Pérez Arellano JL, et al. Diagnóstico y tratamiento de la malaria importada en España: recomendaciones del Grupo de Trabajo de Malaria de la Sociedad Española de Medicina Tropical y Salud Internacional (SEMTSI). Enferm Infecc Microbiol Clin. 2015 Jun-jul;33(6):369-434. DOI: http://dx.doi.org/10.1016/j.eimc.2013.12.014

  19. Peña Molina E, Rodríguez Justiz F, Pividal Grana J. Paludismo importado en Cuba: algunas consideraciones sobre su epidemiología, vigilancia y control. Rev Cub Med Trop. 1988;40(2):82-96.

  20. Anvikar AR, van Eijk AM, Shah A, Upadhyay MKL, Sullivan SA, Patel AK, et al. Clinical and epidemiological characterization of severe Plasmodium vivax malaria in Gujarat, India. Virulence. 2020;11:1730-8. DOI: https://doi.org/10.1080/21505594.2020.1773107

  21. Iborra MA, García E, Carrilero B, Segovia M. Malaria diagnosis and treatment: analyse of a cohort of hospitalized patients at a tertiary level hospital (1998-2010). Rev Esp Quimioter. 2013 [Acceso 30/06/2021];26(1):6-11. Disponible en: Disponible en: https://pubmed.ncbi.nlm.nih.gov/23546456/

  22. Daniels RF, Bineta Deme A, Gomis JF, Dieye B, Durfee K, Thwing JI, et al. Evidence of non-Plasmodium falciparum malaria infection in Kédougou, Senegal. Malar J. 2017;16(9):3-7. DOI: https://doi.org/10.1186/s12936-016-1661-3

  23. Calderaro A, Piccolo G, Montecchini S, Buttrini M, Rossi S, Dell'Anna ML, et al. High prevalence of malaria in a non-endemic setting: comparison of diagnostic tools and patient outcome during a four-year survey (2013-2017) Malar J. 2018;17:63. DOI: https://doi.org/10.1186/s12936-018-2218-4

  24. Cao Y, Wang W, Liu Y, Cotter C, Zhou H, Zhu G, et al. The increasing importance of Plasmodium ovale and Plasmodium malariae in a malaria elimination setting: an observational study of imported cases in Jiangsu Province, China, 2011-2014. Malar J. 2016;15:459. DOI: https://doi.org/10.1186/s12936-016-1504-2

  25. Doctor SM, Liu Y, Anderson OG, Whitesell AN, Kashamuka Mwandagalirwa M, Muwonga J, et al. Low prevalence of Plasmodium malariae and Plasmodium ovale mono-infections among children in the Democratic Republic of the Congo: a population-based, cross-sectional study. Malar J. 2016;15:350. DOI: https://doi.org/10.1186/s12936-016-1409-0




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Cubana Med Trop. 2022;74